Kronos Bio, Inc.
KRON · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$86,079 | -$112,673 | -$133,204 | -$151,078 |
| Dep. & Amort. | $1,716 | $2,136 | $2,266 | $1,977 |
| Deferred Tax | $0 | $0 | $0 | $3,997 |
| Stock-Based Comp. | $9,217 | $24,982 | $31,145 | $26,211 |
| Change in WC | -$17,893 | $5,876 | $6,178 | -$1,620 |
| Other Non-Cash | $27,604 | $1,097 | $2,689 | $2,589 |
| Operating Cash Flow | -$65,435 | -$78,582 | -$90,926 | -$117,924 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$679 | -$577 | -$4,260 |
| Net Acquisitions | $0 | $0 | $31,645 | -$67,984 |
| Inv. Purchases | -$89,232 | -$212,957 | -$367,124 | -$177,734 |
| Inv. Sales/Matur. | $174,671 | $280,004 | $335,479 | $245,718 |
| Other Inv. Act. | $0 | $0 | -$31,645 | $67,984 |
| Investing Cash Flow | $85,435 | $66,368 | -$32,222 | $63,724 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$5 |
| Stock Issued | $0 | $567 | $851 | $4,465 |
| Stock Repurch. | $244 | $538 | $380 | $1,338 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $245 | $567 | $851 | $4,465 |
| Financing Cash Flow | $245 | $567 | $851 | $4,460 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $20,245 | -$11,647 | -$122,297 | -$49,740 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $66,352 | $77,999 | $200,296 | $250,036 |
| End Cash | $86,597 | $66,352 | $77,999 | $200,296 |
| Free Cash Flow | -$65,439 | -$79,261 | -$91,503 | -$122,184 |